| 发明名称 | Medicament for treatment cancer | ||
| 摘要 | A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient. | ||
| 申请公布号 | US9139658(B2) | 申请公布日期 | 2015.09.22 |
| 申请号 | US201012978275 | 申请日期 | 2010.12.23 |
| 申请人 | SUMITOMO DAINIPPON PHARMA CO., LTD. | 发明人 | Noguchi Toshihiro;Baba Akemi;Hanada Mitsuharu |
| 分类号 | A61K39/395;A61K31/704;C07K16/32;A61K31/7036;A61K39/00 | 主分类号 | A61K39/395 |
| 代理机构 | Birch, Stewart, Kolasch & Birch, LLP | 代理人 | Birch, Stewart, Kolasch & Birch, LLP |
| 主权项 | 1. A method of treating breast cancer, which is a breast cancer in which HER2 is highly expressed, comprising administering a first composition including an effective amount of amrubicin, amrubicinol, or a pharmaceutically acceptable salt thereof and a second composition including an effective amount of trastuzumab. | ||
| 地址 | Osaka-Shi JP | ||